These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 6326330)

  • 1. Complement activation in factor D-deficient mice.
    Xu Y; Ma M; Ippolito GC; Schroeder HW; Carroll MC; Volanakis JE
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14577-82. PubMed ID: 11724962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Challenges and Promise of Complement Therapeutics for Ocular Diseases.
    Park DH; Connor KM; Lambris JD
    Front Immunol; 2019; 10():1007. PubMed ID: 31156618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstitution of the alternative pathway of the complement system enables rapid delineation of the mechanism of action of novel inhibitors.
    Goodrich AC; LeClair NP; Shillova N; Morton WD; Wittwer AJ; Loyet KM; Hannoush RN
    J Biol Chem; 2024 Jul; 300(7):107467. PubMed ID: 38876307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement Factor D as a Strategic Target for Regulating the Alternative Complement Pathway.
    Barratt J; Weitz I
    Front Immunol; 2021; 12():712572. PubMed ID: 34566967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Functional Assay to Characterize Mutations in Alternative Pathway of Complement.
    Gerber GF; Pan XZ; Lederman HM; Brady TM; Brodsky RA
    J Clin Immunol; 2023 Aug; 43(6):1134-1136. PubMed ID: 37099066
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation of the alternative complement pathway.
    Fearon DT
    CRC Crit Rev Immunol; 1979 Nov; 1(1):1-32. PubMed ID: 162484
    [No Abstract]   [Full Text] [Related]  

  • 7. [Alternative complement pathway (author's transl)].
    Kazatchkine M; Nydegger U; Fearon DT
    Nouv Presse Med; 1979 Jun; 8(26):2187-94. PubMed ID: 382108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
    Fishelson Z; Müller-Eberhard HJ
    J Immunol; 1984 Mar; 132(3):1425-9. PubMed ID: 6229580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kallikrein Cleaves C3 and Activates Complement.
    Irmscher S; Döring N; Halder LD; Jo EAH; Kopka I; Dunker C; Jacobsen ID; Luo S; Slevogt H; Lorkowski S; Beyersdorf N; Zipfel PF; Skerka C
    J Innate Immun; 2018; 10(2):94-105. PubMed ID: 29237166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alternative complement pathway].
    Jouvin MH; Kazatchkine M
    Sem Hop; 1984 May; 60(19):1371-8. PubMed ID: 6326330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The alternative complement pathway].
    Jouvin MH; Kazatchkine M
    Pathol Biol (Paris); 1983 Dec; 31(10):839-46. PubMed ID: 6230588
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.